[TECHNOLOGY]
Harnessing the power of
Next Generation Sequencing (NGS)
Next-generation sequencing (NGS) is transforming infectious disease diagnostics. Unlike conventional tests with limited detection, NGS screens bacteria, viruses, fungi, parasites, and antibiotic resistance genes (ARGs) simultaneously from a single sample.
Direct sequencing enables unbiased, comprehensive detection, leading to faster, more precise diagnosis and guidance for targeted therapy.
HaystackAnalytics, with its innovative clinical genomic solutions, infexn® powered by Universal ID™ CE-IVD (DNA enrichment kit) and the proprietary bioinformatics platform Ω ID™, is now bringing a transformative precision to infection management.
Upgrade Convention with infexn®
Culture
Microscopy
Immunoassay
PCR
Prior expertise required
Resource intensive
Targeted approach
Interpretive ambiguity
Low sensitivity/specificity
What the infexn® report covers
Pathogens
All bacteria, fungi and major respiratory & neuropathic viruses
ESKAPE pathogens considered
Reliable detection of polymicrobial and co-infections
Antibiotic Resistance Genses (ARGs)
Detection of major ARGs
Enables antimicrobial stewardship
Assists tailored antimicrobial therapy
Getting started
At moments of criticality, the field-tested infexn® workflow can give you accurate results quicker than conventional tests in a few simple steps:
[PARTNER]
Collaborate with us
[ABOUT US]
The leadership team
Prof. Kiran Kondabagil
Co-founder & Chief Scientific Mentor
HaystackAnalytics Pvt. Ltd.
Dr. Anirvan Chatterjee
Co-founder & CEO
HaystackAnalytics Pvt. Ltd.
Gaurav Srivastav
Co founder & COO
HaystackAnalytics Pvt. Ltd.
Scientific Advisory Board
Dr. Aruna Poojary
Dr. Arunaloke Chakraborti
Dr. Pallab Ray
Dr. S K Todi
Testimonials
Dr. Nikhileshwar Prasad Verma
MBBS, MD, FICP
Internal Medicine Specialist
"infexn® is a time-saving procedure to identify and choose antibiotics properly."
Dr. Ashit Naik
MBBS, MD
Pain Physician and Intensivist
Shri Medishine Hospital, Raipur
"infexn® has improved how I diagnose infections in patients. It has helped identify pathogens which were previously undiagnosed by conventional methods and has helped create personalized treatments and also in saving lives. infexn® is reliable and has an effective impact for patient care."
Dr. Alfia Alim
MBBS, MD
Consultant Microbiologist & Head of Infection Control
Mediversal Multi-Super Specialty Hospital
"Reliable and timely diagnosis of pathogens in critically ill patients still poses major problems for intensive care medicine. Using Next Generation Sequencing (NGS) in combination with bioinformatic algorithms, this process is able to detect DNA fragments of pathogens in the patient's blood to identify the cause of the sepsis with highest specificity and sensitivity. NGS offered by HaystackAnalytics (infexn®) has a detection rate five to six times better than that of culture-based procedures with far less turnaround time."
Dr. Nikhileshwar Prasad Verma
MBBS, MD, FICP
Internal Medicine Specialist
"infexn® is a time-saving procedure to identify and choose antibiotics properly."
Dr. Ashit Naik
MBBS, MD
Pain Physician and Intensivist
Shri Medishine Hospital, Raipur
"infexn® has improved how I diagnose infections in patients. It has helped identify pathogens which were previously undiagnosed by conventional methods and has helped create personalized treatments and also in saving lives. infexn® is reliable and has an effective impact for patient care."